Latest news for MarineMax (NYSE:HZO) Stock

MarineMax

MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S.

workday shutter2

News

Short Ideas

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

PAYC

WDAY

Workday, Buckle And 2 Other Stocks Executives Are Selling

Penny,Stock,Investments,Taking,Off,Concept

Intraday Update

Movers

AEHL

AEHR

ALAR

ANVS

CETU

DLPN

FENG

FUFU

GATO

IDYA

IONM

KRUS

KZIA

LGMK

LGVN

LNTH

LUCY

NAAS

NISN

QURE

RMCF

RXST

SDST

SEEL

SISI

SNGX

TCJH

TMDX

VRPX

VSEE

VVPR

ZAPP

Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

APLD

ILMN

Nuveen Arizona Dividend Advantage Municipal Funds 3

VSTS

SMART Global Posts Upbeat Results, Joins Aehr Test Systems, MarineMax And Other Big Stocks Moving Higher On Wednesday

MarineMax Inc

WIIM

CJET

DENN

FRZA

GSUN

JZXN

LAZR

MGOL

PENN

PLBY

PTON

SERV

TDUP

VEEE

YOSH

Shares of companies within the broader consumer discretionary sector are trading higher following better-than-expected consumer sentiment data. Strong earnings from RH and anticipated rate cuts may be lifting the sector.

The Nasdaq 100 closed higher by over 1% during Monday's session. Investors, meanwhile, focused on some notable insider trades.
When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.
Below is a look at a few recent notable insider sales. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Workday</h3>
<ul>
<li>The Trade: Workday, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NASDAQ">WDAY</a>) Director George J Still Jr <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 7,500 shares</a> at an average price of $255.45. The insider received around $1.9 million from selling those shares.</li>
<li>What's Happening: On Aug. 22, Workday reported better-than-expected second-quarter financial results and approved a new buyback program to repurchase up to an additional $1.0 billion of shares of its Class A common stock.</li>
<li>What Workday Does: Workday is a software company that offers human capital management, or HCM, financial management, and business planning solutions.</li>
</ul>
<h3 class="wp-block-heading">Buckle</h3>
<ul>
<li>The Trade: The Buckle, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKE#NYSE">BKE</a>) SVP Leasing Brett P Milkie <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 16,000 shares</a> at an average price of $41.35. The insider received around $661,560 from selling those shares.</li>
<li>What's Happening: On Aug. 23, Buckle reported better-than-expected second-quarter revenue results.</li>
<li>What Buckle Does: Buckle Inc is a retailer of casual apparel, footwear, and accessories.</li>
</ul>
<h3 class="wp-block-heading">Paycom Software</h3>
<ul>
<li>The Trade: Paycom Software, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAYC#NYSE">PAYC</a>) CEO and President Chad R. Richison <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 3,900 shares</a> at an average price of $155.46. The insider received around $606,298 from selling those shares.</li>
<li>What's Happening: On July 31, Paycom Software posted upbeat quarterly earnings</li>
<li>What Paycom Software Does: Paycom is a fast-growing provider of payroll and human capital management software primarily targeting clients with 50-10,000 employees in the United States.</li>
</ul>
<h3 class="wp-block-heading">MarineMax</h3>
<ul>
<li>The Trade: MarineMax, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) Clint Moore <a href="https://www.benzinga.com/sec/insider-trades/">sold a total of 2,500 shares</a> at an average price of $30.03. The insider received around $75,075 from selling those shares.</li>
<li>What's Happening: On Sept. 9, Citigroup analyst James Hardiman upgraded MarineMax from Neutral to Buy and raised the price target from $40 to $44.</li>
<li>What MarineMax Does: MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories.</li>
</ul>
Check This Out: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40785814/dow-jumps-over-1-following-last-weeks-selloff-investor-sentiment-improves-but-fear-greed-index-rema">Dow Jumps Over 1% Following Last Week&#8217;s Selloff: Investor Sentiment Improves, But Fear &amp; Greed Index Remains In &#8216;Fear&#8217; Zone</a></li>
</ul>

Ratings for MarineMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $42.17, a high estimate of $46.00, and a low estimate of $37.00. This upward trend is apparent, with the current average reflecting a 10.48% increase from the previous average price target of $38.17.
<img src="https://www.benzinga.com/files/images/story/2024/1725890418_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The perception of MarineMax by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>James Hardiman</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$44.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Brandon Rolle</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$42.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Michael Swartz</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$44.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Brandon Rolle</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$37.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Drew Crum</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$40.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Eric Wold</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$46.00</td>
<td>$48.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to MarineMax. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of MarineMax compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of MarineMax's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of MarineMax's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/HZO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on MarineMax analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>All You Need to Know About MarineMax</h2>
MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S.
<h3>Understanding the Numbers: MarineMax's Finances</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Positive Revenue Trend: Examining MarineMax's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.97% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: MarineMax's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.16% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): MarineMax's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 3.32%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.21%, the company showcases effective utilization of assets.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.28.
<h2>How Are Analyst Ratings Determined?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

The Analyst Landscape: 6 Takes On MarineMax

Citigroup analyst James Hardiman upgrades MarineMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) from Neutral to Buy and raises the price target from $40 to $44.

Upgrades

Price Target

Citigroup Upgrades MarineMax to Buy, Raises Price Target to $44

Disclosed on August 22, Kyle Langbehn, EVP at MarineMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>), executed a substantial insider sell as per the latest SEC filing.
What Happened: After conducting a thorough analysis, Langbehn sold 10,000 shares of MarineMax. This information was disclosed in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001057060/000095017024099854//Archives/edgar/data/1057060/000095017024099854/0000950170-24-099854-index.htm">U.S. Securities and Exchange Commission</a> on Thursday. The total transaction value is $307,800.
The latest update on Friday morning shows MarineMax shares down by 0.0%, trading at $30.02.
<h3>About MarineMax</h3>
MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S.
<h3>MarineMax: Delving into Financials</h3>
Revenue Growth: Over the 3 months period, MarineMax showcased positive performance, achieving a revenue growth rate of 4.97% as of 30 June, 2024. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.
Analyzing Profitability Metrics:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 31.95%, suggesting potential challenges in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): MarineMax's EPS is notably higher than the industry average. The company achieved a positive bottom-line trend with a current EPS of 1.42.
</li>
</ul>
Debt Management: MarineMax's debt-to-equity ratio surpasses industry norms, standing at 1.28. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: MarineMax's P/E ratio of 14.09 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: With a P/S ratio of 0.28 below industry standards, the stock shows potential undervaluation, making it an appealing investment option for those focusing on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With an EV/EBITDA ratio lower than industry benchmarks at 9.11, MarineMax presents an attractive value opportunity.
</li>
</ul>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Delving Into the Significance of Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>A Closer Look at Important Transaction Codes</h3>
When dissecting transactions, the focal point for <a href="https://www.benzinga.com/money/investing-tools">investors</a> is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001057060">Check Out The Full List Of MarineMax's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

EVP At MarineMax Sells $307K Of Stock

Transaction Better Positions MasterCraft to Execute Strategic Growth Initiatives with Enhanced Operational Focus 
&nbsp;
MasterCraft to Wind Down Merritt Island Production Facility Operations and Commence Marketing of Property for Sale
Aviara Segment to be Reported as Discontinued Operations Beginning&nbsp;First Quarter&nbsp;Fiscal Year 2025
&nbsp;
&nbsp;MasterCraft Boat Holdings, Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/MCFT#NASDAQ">MCFT</a>) (&quot;MasterCraft&quot; or the &quot;Company&quot;) today announced that it has entered into an asset exchange agreement under which it will transfer the rights to its Aviara brand of luxury dayboats and related assets to Cruisers Yachts, a subsidiary of MarineMax, Inc. (&quot;MarineMax&quot;).
&nbsp;
Under the terms of the agreement, MasterCraft will transfer ownership of the Aviara brand, including all commercial and operational assets relating to Aviara&#39;s product line, to Cruisers Yachts. As part of the asset exchange, MarineMax will pay for all boats currently on order, in addition to select branding and operational assets, including Aviara&#39;s website, tooling and inventory. MarineMax will also assume Aviara&#39;s customer care, warranty liability and administration. MasterCraft will discontinue operations of the Aviara segment, close its Merritt Island, Florida production facility and offer the property for open market sale. Other financial details of the agreement were not disclosed.

MCFT

Marinemax Enters Asset Exchange Agreement With Mastercraft Boat Holdings; Cruisers Yachts To Assume Aviara Brand Of Luxury Dayboats; Marinemax Receives Assets Including Molds, Tooling, And Inventory; Other Financial Terms Not Disclosed

A substantial insider sell was reported on July 31, by Kyle Langbehn, EVP at MarineMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>), based on the recent SEC filing.
What Happened: A Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001057060/000095017024088559//Archives/edgar/data/1057060/000095017024088559/0000950170-24-088559-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday outlined that Langbehn executed a sale of 10,000 shares of MarineMax with a total value of $372,400.
MarineMax's shares are actively trading at $34.87, experiencing a down of 0.0% during Thursday's morning session.
<h3>All You Need to Know About MarineMax</h3>
MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S.
<h3>Financial Milestones: MarineMax's Journey</h3>
Revenue Growth: MarineMax's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 4.97%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Evaluating Earnings Performance:
<ul>
<li>
Gross Margin: The company shows a low gross margin of 31.95%, suggesting potential challenges in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): MarineMax's EPS reflects a decline, falling below the industry average with a current EPS of 1.42.
</li>
</ul>
Debt Management: With a high debt-to-equity ratio of 1.28, MarineMax faces challenges in effectively managing its debt levels, indicating potential financial strain.
Financial Valuation Breakdown:
<ul>
<li>
Price to Earnings (P/E) Ratio: The current P/E ratio of 16.37 is below industry norms, indicating potential undervaluation and presenting an investment opportunity.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 0.32 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio of 9.7 trails industry averages, indicating a potential disparity in market valuation that could be advantageous for investors.
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Navigating the Impact of Insider Transactions on Investments</h3>
Investors should view insider transactions as part of a multifaceted analysis and not rely solely on them for decision-making.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Understanding Crucial Transaction Codes</h3>
<a href="https://www.benzinga.com/money/investing-tools">Investors</a> prefer focusing on transactions that take place in the open market, indicated in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S indicates a sale. Transaction code C indicates the conversion of an option, and transaction code A indicates grant, award or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001057060">Check Out The Full List Of MarineMax's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Massive Insider Trade At MarineMax

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on MarineMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) in the last three months.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for MarineMax, presenting an average target of $41.8, a high estimate of $46.00, and a low estimate of $37.00. This upward trend is evident, with the current average reflecting a 10.58% increase from the previous average price target of $37.80.
<img src="https://www.benzinga.com/files/images/story/2024/1722258016_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The standing of MarineMax among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brandon Rolle</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$42.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Michael Swartz</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$44.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Brandon Rolle</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$37.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Drew Crum</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$40.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Eric Wold</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$46.00</td>
<td>$48.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to MarineMax. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of MarineMax compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of MarineMax's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of MarineMax's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HZO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on MarineMax analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About MarineMax</h2>
MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S.
<h3>Understanding the Numbers: MarineMax's Finances</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining MarineMax's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 4.97% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 4.16%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 3.32%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): MarineMax's ROA stands out, surpassing industry averages. With an impressive ROA of 1.21%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: MarineMax's debt-to-equity ratio is below the industry average. With a ratio of 1.28, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>How Are Analyst Ratings Determined?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Expectations For MarineMax's Future

DA Davidson analyst Brandon Rolle maintains MarineMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) with a Buy and raises the price target from $37 to $42.

DA Davidson Maintains Buy on MarineMax, Raises Price Target to $42

Truist Securities analyst Michael Swartz maintains MarineMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) with a Buy and raises the price target from $35 to $44.

Truist Securities Maintains Buy on MarineMax, Raises Price Target to $44

Guidance

MarineMax Reaffirms FY24 Adj EPS Outlook Of $2.20 - $3.20 Vs. $2.37 Est.

MarineMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) reported quarterly earnings of $1.51 per share which beat the analyst consensus estimate of $1.40 by 7.86 percent. This is a 27.05 percent decrease over earnings of $2.07 per share from the same period last year. The company reported quarterly sales of $757.72 million which beat the analyst consensus estimate of $725.82 million by 4.40 percent. This is a 4.97 percent increase over sales of $721.84 million the same period last year.

Earnings

Earnings Beats

MarineMax Q3 Adj $1.51 Beats $1.40 Estimate, Sales $757.72M Beat $725.82M Estimate

DA Davidson analyst Brandon Rolle maintains MarineMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) with a Buy and raises the price target from $34 to $37.

DA Davidson Maintains Buy on MarineMax, Raises Price Target to $37

According to MarineMax's definitive proxy statement for the 2024 Annual Meeting of Shareholders, as of December 18, 2023 (the record date for the Annual Meeting), compensation for senior management well exceeds $10 million per year, costing shareholders $50 million to $100 million of value at a time when the EBITDA run rate of the Company has fallen by more than $100 million. The stock price has fallen by more than 40% in the past three years.

Management

Island Capital Group Questions MarineMax's Operating Strategy Amid Deteriorating Performance; Says "Compensation For Senior Management Well Exceeds $10M Per Year, Costing Shareholders $50M-$100M Of Value At A Time When The EBITDA Run Rate Of The Co Has Fallen By More Than $100M, The Stock Price Has Fallen By More Than 40% In The Past 3-Years"

Analysts' ratings for MarineMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) over the last quarter vary from bullish to bearish, as provided by 4 analysts.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $39.0, along with a high estimate of $46.00 and a low estimate of $35.00. A decline of 2.5% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2024/1720789262_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
The standing of MarineMax among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Drew Crum</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$40.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Eric Wold</td>
<td>B. Riley Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$46.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Michael Swartz</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$35.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Drew Crum</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$35.00</td>
<td>$37.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to MarineMax. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of MarineMax compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Capture valuable insights into MarineMax's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/HZO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on MarineMax analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind MarineMax</h2>
MarineMax Inc is a United-States-based company that sells new and used recreational boats under premium brands, and related marine products, like engines, parts, and accessories. The company is also engaged in other businesses, including providing services of repair, maintenance, and storage; managing related boat financing, insurance, and others; offering brokerage sales of boats and yachts; and operating a yacht charter business. The reportable segments of the company are Retail Operations and Product Manufacturing. The Retail Operations segment generates the majority of the company's revenue. The sale of new and used boats accounts for the majority of the company's total revenue. It serves customers across the U.S.
<h3>A Deep Dive into MarineMax's Financials</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: MarineMax's revenue growth over a period of 3 months has been noteworthy. As of 31 March, 2024, the company achieved a revenue growth rate of approximately 2.2%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Consumer Discretionary sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: MarineMax's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of 0.27%, the company may face hurdles in effective cost management.
Return on Equity (ROE): MarineMax's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 0.17%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): MarineMax's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.06%, the company may face hurdles in achieving optimal financial returns.
Debt Management: MarineMax's debt-to-equity ratio surpasses industry norms, standing at 1.37. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>What Are Analyst Ratings?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: MarineMax Through The Eyes Of 4 Analysts

Today, Island Capital Group LLC issued an updated letter to the shareholders of MarineMax, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>). The full text of the letter follows:
July 12, 2024
Dear MarineMax Shareholders,
I am disappointed to report that we have not heard from any member of the management team or the board of directors of MarineMax, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) ("MarineMax" or the "Company") since we published our open letter to you earlier this week. We have not heard from any of the Company's financial or other advisors either. I assume that must be disappointing to you as well.
I am humbly encouraged by your support of our proposal to acquire the YMRS Business from MarineMax, as evidenced by recent trading activity in the Company's stock. The closing share price on July 9 (the day I sent my initial letter) was $30.36, and yesterday's closing price was $36.07 – a 19% increase. The market clearly recognizes that our proposal would unlock material value for MarineMax's shareholders.
As noted in my original letter, Island Capital and its affiliates have a material stake in MarineMax given the earnout payment due to us in less than a year, which is carried at $67.7 million on the Company's balance sheet as of its most recent 10-K (dated September 30, 2023). At this valuation, our interest approximates 8% of the Company's equity market capitalization (10% before the increase in the Company's stock price over the past two days) – which makes us one of MarineMax's largest stakeholders. In comparison, the Company's board of directors and management team (16 people in total) collectively own only 4% of MarineMax's equity. The simple reality is that the value of the ongoing (status quo) compensation prospects for the Company's management team significantly exceeds the value of their equity stakes (which makes them misaligned with you, the Company's owners).
In sum, our proposed transaction is in the best interests of MarineMax and its shareholders, as it would provide the Company with liquidity to deploy for debt reduction, growth opportunities and/or or stock repurchases. I urge you to reach out to the board and management of MarineMax to let them know that you support this proposal and request that they engage with us immediately.
Thank you,
Andrew L. Farkas Managing Member, Chairman &amp; CEO

Island Capital Group Chairman And CEO Andrew L. Farkas Reinforces Its Proposed Transaction As Being In The Best Interests Of MarineMax And Its Shareholders

Stifel analyst Drew Crum maintains MarineMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) with a Buy and raises the price target from $35 to $40.

Stifel Maintains Buy on MarineMax, Raises Price Target to $40

B. Riley Securities analyst Eric Wold maintains MarineMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) with a Buy and lowers the price target from $48 to $46.

B. Riley Securities Maintains Buy on MarineMax, Lowers Price Target to $46

Shares of SeaStar Medical Holding Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICU#NASDAQ">ICU</a>) fell sharply during Wednesday's session after the company entered into a $10 million registered direct offering of 947,868 <a href="https://www.benzinga.com/quote/ICU/news">shares at $10.55 per share</a>.
SeaStar Medical shares dipped 34% to $8.55 on Wednesday.
Here are some other stocks moving in today&#8217;s mid-day session.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>Virpax Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRPX#NASDAQ">VRPX</a>) shares jumped 139% to $2.78 after the company announced results for a Swine Model pilot study for Probudur.</li>
<li>Kazia Therapeutics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KZIA#NASDAQ">KZIA</a>) gained 129% to $0.4325 after the company announced results from GBM-AGILE, a phase II/III study that included an evaluation of paxalisib versus standard of care for patients with glioblastoma.</li>
<li>Longeveron Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVN#NASDAQ">LGVN</a>) surged 81.8% to $5.21 after the company announced that the FDA granted Regenerative Medicine Advanced Therapy designation to Lomecel-B for the treatment of mild Alzheimer&#8217;s Disease.</li>
<li>VivoPower International PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VVPR#NASDAQ">VVPR</a>) shares climbed 56.8% to $4.00 after the company announced it secured an extension for a $34 million loan financing facility agreement.</li>
<li>Ampco-Pittsburgh Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AP#NYSE">AP</a>) rose 41.2% to $1.08.</li>
<li>NaaS Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAAS#NASDAQ">NAAS</a>) gained 34.3% to $4.3650 after surging 68% on Tuesday.</li>
<li>Phoenix New Media Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FENG#NYSE">FENG</a>) climbed 33% to $3.58.</li>
<li>Solaris Oilfield Infrastructure, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOI#NYSE">SOI</a>) climbed 29% to $10.67. Solaris Oilfield Infrastructure agreed to acquire Mobile Energy Rentals LLC for $200 million.</li>
<li>Lantheus Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNTH#NASDAQ">LNTH</a>) gained 28.6% to $99.97. Lantheus recently appointed Jamie Spaeth as Chief People Officer.</li>
<li>Antelope Enterprise Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHL#NASDAQ">AEHL</a>) gained 27% to $4.60.</li>
<li>Innovative Eyewear, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUCY#NASDAQ">LUCY</a>) rose 25% to $0.4750.</li>
<li>uniQure N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QURE#NASDAQ">QURE</a>) rose 22.6% to $8.19.</li>
<li>Aehr Test Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHR#NASDAQ">AEHR</a>) gained 21.4% to $15.05 after the company provided preliminary fourth-quarter and FY24 financial results.</li>
<li>Quhuo Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QH#NASDAQ">QH</a>) gained 21.1% to $0.5208.</li>
<li>Rocky Mountain Chocolate Factory, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RMCF#NASDAQ">RMCF</a>) climbed 18.1% to $2.08. Rocky Mountain Chocolate Factory is expected to report first-quarter results on Monday, July 15.</li>
<li>SMART Global Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGH#NASDAQ">SGH</a>) gained 17.4% to $27.27 after the company reported better-than-expected third-quarter financial results.</li>
<li>Hawaiian Electric Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HE#NYSE">HE</a>) jumped 15.8% to $9.94.</li>
<li>Nisun International Enterprise Development Group Co., Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NISN#NASDAQ">NISN</a>) gained 15.8% to $7.00.</li>
<li>Gatos Silver, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GATO#NYSE">GATO</a>) gained 15.3% to $12.86 after the company reported second-quarter Production results with record mill throughput and zinc production.</li>
<li>Seelos Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEEL#NASDAQ">SEEL</a>) shares rose 14.4% to $0.7743 after gaining 36% on Tuesday.</li>
<li>Endeavour Silver Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXK#NYSE">EXK</a>) gained 10.2% to $4.3801. HC Wainwright &amp; Co. analyst Heiko Ihle reiterated Endeavour Silver with a Buy and maintained a $6.25 price target.</li>
<li>MarineMax, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) rose 9.3% to $33.18 after Island Capital issued an open letter to shareholders and made an open proposal to acquire up to 100% interest in the YMRS business from MarineMax.</li>
<li>Soligenix, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNGX#NASDAQ">SNGX</a>) shares rose 7.4% to $7.97. Soligenix shares jumped 271% on Tuesday after the company announced interim results for extended HyBryte treatment in early-stage CTCL patients.</li>
<li>CarMax, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMX#NYSE">KMX</a>) gained 5.2% to $76.03.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Shineco, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SISI#NASDAQ">SISI</a>) shares fell 40.1% to $2.70. Shineco's subsidiary Fuzhou Meida signed distribution agreements for water-soluble phospholipid concentrate beverage.</li>
<li>Zapp Electric Vehicles Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZAPP#NASDAQ">ZAPP</a>) fell 38.2% to $11.10 after jumping 94% on Tuesday.</li>
<li>Stardust Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDST#NASDAQ">SDST</a>) fell 31.5% to $7.11 after gaining around 9% on Tuesday.</li>
<li>LegalZoom.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZ#NASDAQ">LZ</a>) shares fell 25.7% to $5.84 after the company announced a CEO transition and lowered its full year guidance.</li>
<li>Alarum Technologies Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAR#NASDAQ">ALAR</a>) declined 25% to $33.45 after the company announced estimated guidance for the first half of 2024.</li>
<li>Top KingWin Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCJH#NASDAQ">TCJH</a>) shares dipped 22.7% to $0.28.</li>
<li>Cetus Capital Acquisition Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETU#NASDAQ">CETU</a>) fell 21.5% to $6.04.</li>
<li>VSee Health, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSEE#NASDAQ">VSEE</a>) fell 19.2% to $5.64.</li>
<li>Dolphin Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLPN#NASDAQ">DLPN</a>) fell 18.4% to $0.6530.</li>
<li>Assure Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IONM#NASDAQ">IONM</a>) fell 17.2% to $4.21.</li>
<li>Annovis Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANVS#NASDAQ">ANVS</a>) declined 16.6% to $12.14.</li>
<li>RxSight, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXST#NASDAQ">RXST</a>) fell 16.6% to $47.52. Stifel analyst Thomas Stephan maintained RxSight with a Buy and lowered the price target from $75 to $70.</li>
<li>10x Genomics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXG#NASDAQ">TXG</a>) shares declined 14.2% to $15.65. On Tuesday, Goldman Sachs analyst Matthew Sykes maintained 10x Genomics with a Sell and lowered the price target from $26 to $16.</li>
<li>LogicMark, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) shares declined 12.2% to $0.5875 after gaining around 22% on Tuesday.</li>
<li>Ziff Davis, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZD#NASDAQ">ZD</a>) fell 11.6% to $45.83.</li>
<li>Kura Sushi USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRUS#NASDAQ">KRUS</a>) fell 10.6% to $52.29 after the company posted downbeat results for its third quarter on Tuesday.</li>
<li>Hudson Pacific Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPP#NYSE">HPP</a>) declined 10.4% to $4.6150. Morgan Stanley analyst Ronald Kamdem downgraded Hudson Pacific Properties from Equal-Weight to Underweight and lowered the price target from $6 to $4.25.</li>
<li>BitFuFu Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUFU#NASDAQ">FUFU</a>) fell 9.7% to $4.6817.</li>
<li>ZoomInfo Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZI#NASDAQ">ZI</a>) fell 6.6% to $11.65.</li>
<li>TransMedics Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMDX#NASDAQ">TMDX</a>) declined 6.1% to $138.81.</li>
<li>IDEAYA Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDYA#NASDAQ">IDYA</a>) fell 5.4% to $36.59. IDEAYA priced $263 million public offering of 228,572 common shares and pre-funded warrants at $35 per share.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/24/07/39709532/apple-to-rally-around-14-here-are-10-top-analyst-forecasts-for-wednesday">Apple To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday</a>

Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

MarineMax shares are trading higher after Island Capital issued an open letter to shareholders and made an open proposal to acquire up to 100% interest in the YMRS business from MarineMax.

Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on Marinemax (HZO – Research Report), QuantumS...

Analysts Offer Insights on Consumer Cyclical Companies: Marinemax (HZO), QuantumScape (QS) and Mohawk (MHK)

MarineMax: Q3 And M&A Speculation Show Improving Fundamentals In Challenging Industry

In a report released today, Brandon Rolle from D.A. Davidson reiterated a Buy rating on Marinemax (HZO – Research Report), with a price target of $...

Marinemax (HZO) Receives a Buy from D.A. Davidson

MarineMax enters into asset exchange agreement with MasterCraft Boat Holdings

Leisure vehicles about to get a Fed bump

Marinemax (HZO – Research Report), the Consumer Cyclical sector company, was revisited by a Wall Street analyst today. Analyst Eric Wold from B.Ril...

Buy Rating Affirmed for MarineMax on Strategic Positioning and Financial Strength

Powell put drives up interest rate sensitive stocks

Powell put drives up interest rate-sensitive stocks

Marinemax (HZO) has issued an announcement. Hilliard M. Eure III resigned from MarineMax, Inc.'s Board of Directors, effective September 1, 2024, w...

MarineMax Announces Board Reshuffle and New Audit Chair

MarineMax could benefit 'mightily' from a Fed pivot - analyst

BYON

GORV

LCII

LIND

MBUU

NCLH

ONEW

SFIX

Academy Sports and Outdoors, Inc. - Common Stock

Academy Sports

BARK

Build-A-Bear Workshop

Bath & Body Works

Barnes & Noble Education, Inc Common Stock

Barnes & Noble Education

Chewy

Dick's Sporting Goods

Envela

National Vision Holdings, Inc. - Common Stock

National Vision Holdings

Five Below

1-800-FLOWERS.COM, Inc. - Class A Common Stock

1-800-Flowers.com

Fitell

Grove Collaborative Holdings, Inc. Class A Common Stock

Grove Collaborative Hldgs

Leslies

PetMed Express

Sally Beauty Holdings, Inc. (Name to be changed from Sally Holdings, Inc.) Common Stock

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

MarineMax

News

Latest news for MarineMax (NYSE:HZO) Stock

People Also Watch